Journal article

Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study

Dusan Kotasek, Niall Tebbutt, Jayesh Desai, Stephen Welch, Lillian L Siu, Sheryl McCoy, Yu-Nien Sun, Jessica Johnson, Adeboye H Adewoye, Timothy Price

BMC Cancer | BMC | Published : 2011


Funding Acknowledgements

The authors would like to acknowledge Bernd Brunner, PhD, and Cindy Wake, BS, for support of the motesanib and erlotinib bioanalytical analysis and sample coordination; Rebeca Melara, MS, and Jian-Feng Lu, PhD, for contributions to the pharmacokinetic analysis; and Erik Rasmussen, MS, for statistical support. Additionally, the authors would like to thank Benjamin Scott, PhD, and Ali Hassan, PhD (Complete Healthcare Communications, Inc., Chadds Ford, PA), whose work was funded by Amgen Inc., for assistance in writing this manuscript.